Results 181 to 190 of about 21,331 (238)

Case report: BTK inhibitors is effective in type II mixed cryoglobulinemia with wild-type MyD88. [PDF]

open access: yesFront Immunol
Xu M   +12 more
europepmc   +1 more source

Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL. [PDF]

open access: yesBlood Adv
Gentile G   +26 more
europepmc   +1 more source

Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist. [PDF]

open access: yesJ Med Chem
Balıkçı E   +19 more
europepmc   +1 more source

QSAR modelling, molecular docking, molecular dynamic and ADMET prediction of pyrrolopyrimidine derivatives as novel Bruton's tyrosine kinase (BTK) inhibitors. [PDF]

open access: yesSaudi Pharm J
Aloui M   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy